Engineering Antimicrobial Peptides via Motif Assembly for Combating Multidrug-Resistant Pathogens
Journal of Medicinal Chemistry · 26.03.2026 · 69 (6) · 6596-6609
DOI: 10.1021/acs.jmedchem.5c02816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 14.03.2026. Verfasst von Sukhvir Kaur Bhangu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Commonwealth Scientific and Industrial Research Organisation (CSIRO), Manufacturing, Clayton, Victoria 3169, Australia. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Commonwealth Scientific and Industrial Research Organisation.
Abstract (Originalsprache)
Hybridization of common motifs from known antimicrobial peptides (AMPs) is a promising strategy for designing a new class of antimicrobial agents with improved activity. Herein, the machine learning-generated peptide sequence IIKLLGVLAKFVLGQ-NH2 was utilized for sequence optimization using an alanine scan and alignment with known AMPs to identify the motifs with the highest occurrences. Motifs were then assembled to obtain positively charged peptides with 12 to 18 amino acid lengths and hydrophobicity >60%. The designed peptides exhibit broad-spectrum antimicrobial activity against multiple Gram-negative and Gram-positive bacterial strains, along with excellent pH and plasma stability. The peptides demonstrate high efficiency in eradicating bacterial biofilms with no resistance development over 300 generations against a "superbug" clinical strain of Acinetobacter baumannii. Additionally, AMPs were biocompatible and promoted fibroblast migration, which accelerated artificial wound closure. This study highlights an innovative strategy for engineering highly effective AMPs with significant potential in combating multidrug-resistant pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Commonwealth Scientific and Industrial Research Organisation (CSIRO), Manufacturing, Clayton, Victoria 3169, Australia.
- Department of Diabetes, School of Translational Medicine, Monash University, Melbourne, Victoria 3004, Australia.
- Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria 3169, Australia.
- Centre for Inflammatory Diseases, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3169, Australia.
- Florey Institute of Neuroscience and Mental Health and Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria 3010, Australia.
ORCID-Profile: Sukhvir Kaur Bhangu, Fanyi Li, Nicholas G Welch, John D Wade, Mohammed Akhter Hossain, Helmut Thissen
Förderung
- Commonwealth Scientific and Industrial Research Organisation
Zitieren
APA
Bhangu, S. K., Li, F., Xu, R., Vishna Heshini Mendis, T., Welch, N. G., Harris, J., Wade, J. D., Hossain, M. A., Thissen, H., & Kowalczyk, W. (2026). Engineering Antimicrobial Peptides via Motif Assembly for Combating Multidrug-Resistant Pathogens. Journal of Medicinal Chemistry, 69(6), 6596-6609. https://doi.org/10.1021/acs.jmedchem.5c02816
Vancouver
Bhangu SK, Li F, Xu R, Vishna Heshini Mendis T, Welch NG, Harris J, et al. Engineering Antimicrobial Peptides via Motif Assembly for Combating Multidrug-Resistant Pathogens. Journal of Medicinal Chemistry. 2026;69(6):6596-6609. doi:10.1021/acs.jmedchem.5c02816
BibTeX
@article{Bhangu2026,
author = {Bhangu, Sukhvir Kaur and Li, Fanyi and Xu, Rong and Vishna Heshini Mendis, Thirimadura and Welch, Nicholas G and Harris, James and Wade, John D and Hossain, Mohammed Akhter and Thissen, Helmut and Kowalczyk, Wioleta},
title = {Engineering Antimicrobial Peptides via Motif Assembly for Combating Multidrug-Resistant Pathogens},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {6},
pages = {6596--6609},
doi = {10.1021/acs.jmedchem.5c02816}
}
EUVIMED